Request that your members of Congress cosponsor the Steve Gleason Enduring Voices Act of 2017 (H.R. 2465/S. 1132), legislation that builds on the Steve Gleason Act of 2015 to permanently fix Medicare’s policy that limits access to speech-generating devices (SGD).
Ongoing and permanent access to Medicare coverage of SGDs will ensure individuals who medically qualify for an SGD to continue to use their personalized devices. The Steve Gleason Act of 2015 is expected to expire on January 1, 2019. It is important to pass this important legislation.